{"database": "openregs", "table": "dockets", "rows": [["FDA-2022-N-2390", "FDA", "Proposal To Refuse To Approve a New Drug Application Supplement for Hetlioz (Tasimelteon); Opportunity for a Hearing", "Nonrulemaking", "2026-04-14T19:05:51Z", "0b000064853748a9"]], "columns": ["id", "agency_id", "title", "docket_type", "last_modified", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2022-N-2390"], "units": {}, "query_ms": 0.41573704220354557, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}